Effects of Pollen Typhae total flavones on mRNA expressions of peroxisome proliferator-activated receptors in 3T3-L1 adipocytes

Journal of Chinese Integrative Medicine

Volumn 6, Issue 9, 2008, Pages 939-941

  He, Yan Ming ^a   Wang, Wen Jian ^a   Chen, Wei Hua ^a   Ying, Jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

3T3 L1 adipocyte; Free fatty acid; Peroxisome proliferator activated receptors; Pollen Typhae total flavones

Indexed keywords

FLAVONE DERIVATIVE; GLUCOSE; INSULIN SENSITIZING AGENT; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; POLLEN EXTRACT; ROSIGLITAZONE; TYPHAE EXTRACT; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; GLUCOSE METABOLISM; INSULIN SENSITIVITY; LIPID METABOLISM; MOUSE; NONHUMAN; POLLEN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TYPHACEAE; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELLS, CULTURED; FLAVONES; MICE; POLLEN; PPAR ALPHA; PPAR GAMMA; RNA, MESSENGER; TYPHACEAE;

EID: 52949116793     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20080912     Document Type: Article

References (9)

1. Wilding JP. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med. 2007; 24 (9): 934-945.
2. Wang HB, Wang ZY. The research development on the pharmacological function of Pollen Typhae. Yi Yao Dao Bao. 2005; 24 (4): 318-319.
3. He YM, Wang WJ, Chen WH, et al. Effects of Pollen Typhae total flavone on glucose and lipid metabolism in 3T3-L1 adipocytes. Zhong Xi Yi Jie He Xue Bao. 2006; 4(6): 593-595.
4. Takano A, Haruta T, Iwata M, et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. Diabetes. 2001; 50(8): 1891-1900.
5. Duval C, Müller M, Kersten S. PPARalpha and dyslipidemia. Biochim Biophys Acta. 2007; 1771(8): 961-971.
6. Chou FS, Wang PS, Kulp S. Effects of thiazolidinediones on differentiation, proliferation, and apoptosis. Mol Cancer Res. 2007; 5(6): 523-530.
7. Pfützner A, Weber MM, Forst T. Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects. Expert Opin Pharmacother. 2007; 8(12): 1985-1998.
8. Jucker BM, Yang D, Casey WM, et al. Selective PPAR (delta) agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study. Am J Physiol Endocrinol Metab. 2007; 293(5): E1256-E1264.
9. Fagerberg B, Schuster H, Birketvedt GS, et al. Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPAR alpha/gamma agonist, tesaglitazar. Diab Vasc Dis Res. 2007; 4(3): 174-180.